Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
|
CN |
|
Odfjell SE
F:O7F
|
NO |
|
E
|
Encavis AG
XMUN:ECV
|
DE |
|
Airway Medix SA
F:D1C
|
PL |
|
C
|
Chongqing Rural Commercial Bank Co Ltd
F:C3B
|
CN |
Wall St Price Targets
GU5 Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for GU5 is 2.41 EUR with a low forecast of 1.49 EUR and a high forecast of 3.42 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GU5's stock price target?
Price Target
2.41
EUR
According to Wall Street analysts, the average 1-year price target for GU5 is 2.41 EUR with a low forecast of 1.49 EUR and a high forecast of 3.42 EUR.
What is the Revenue forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 10%.
What is the Pre-Tax Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 7%.
